Karbohold GM 1mg/500mg/0.3mg Tablet ER
Marketer
Medxone Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Karbohold GM 1mg/500mg/0.3mg Tablet ER
Diabetic patients using Glucohold MX, a triple-combination anti-diabetic medication (1mg/500mg/0.3mg extended-release tablet), should adhere to their physician's prescribed dosage and regimen. This medication, used in adults to manage type 2 diabetes, regulates blood glucose levels. Administer Glucohold MX with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your doctor based on blood sugar monitoring. Discontinuing Glucohold MX without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. A comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor, is crucial. Common adverse effects include hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them by promptly consuming a fast-acting glucose source like fruit juice or sweets. Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Glucohold MX is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any pre-existing heart conditions before initiating treatment. Pregnant or breastfeeding women must consult their doctor before use. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your doctor, are essential.
Primary Ingredients of Karbohold GM 1mg/500mg/0.3mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Karbohold GM 1mg/500mg/0.3mg Tablet ER
Managing type 2 diabetes
Major Benefits of Karbohold GM 1mg/500mg/0.3mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Karbohold GM 1mg/500mg/0.3mg Extended-Release Tablets on an empty stomach.
Common Side effects of Karbohold GM 1mg/500mg/0.3mg Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Karbohold GM 1mg/500mg/0.3mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Karbohold GM 1mg/500mg/0.3mg Extended-Release Tablets. Ingest the tablet whole; do not break, chew, or crush it. Administer on an empty stomach.
How Karbohold GM 1mg/500mg/0.3mg Tablet ER works:
Extended-release Karbohold GM tablets (1mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Karbohold GM 1mg/500mg/0.3mg Extended-Release Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Karbohold GM 1mg/500mg/0.3mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Karbohold GM tablets (1mg/500mg/0.3mg) are likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The extended-release Karbohold GM 1mg/500mg/0.3mg tablet is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Its use is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with liver impairment should use Karbohold GM 1mg/500mg/0.3mg Extended-Release Tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Karbohold GM 1mg/500mg/0.3mg Tablet ER :
Should you forget to take a Karbohold GM 1mg/500mg/0.3mg Extended-Release Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, forgo the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Karbohold GM 1mg/500mg/0.3mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently